Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 1,333 | 1,556 | 766 | 1,614 | 902 |
| Cost of Goods | 567 | 790 | 502 | 1,296 | 598 |
| Gross Profit | 766 | 766 | 264 | 318 | 304 |
| Operating Expenses | 6,430 | 3,634 | -1,231 | -5,178 | 21,899 |
| Operating Income | -5,097 | -2,078 | 1,997 | 5,792 | -20,997 |
| Interest Expense | 657 | 702 | 669 | 936 | 1,072 |
| Other Income | 415 | 17 | 199 | -406 | 111 |
| Pre-tax Income | -5,339 | -2,763 | 1,527 | 4,450 | -21,958 |
| Net Income Continuous | -5,339 | -2,763 | 1,527 | 4,450 | -21,958 |
| Net Income | $-5,339 | $-2,763 | $1,527 | $4,450 | $-21,958 |
| EPS Basic Total Ops | -0.41 | 0.49 | 0.15 | 0.48 | -3.19 |
| EPS Basic Continuous Ops | -0.41 | 0.48 | 0.15 | 0.48 | -3.10 |
| EPS Diluted Total Ops | -0.41 | 0.52 | 0.15 | 0.45 | -3.19 |
| EPS Diluted Continuous Ops | -0.41 | 0.51 | 0.15 | 0.45 | -3.10 |
| EBITDA(a) | $-4,574 | $-1,481 | $2,462 | $6,332 | $-20,527 |